{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:37:18Z","timestamp":1773812238160,"version":"3.50.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1093\/europace\/eut416","type":"journal-article","created":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T02:06:41Z","timestamp":1390442801000},"page":"1580-1586","source":"Crossref","is-referenced-by-count":20,"title":["Awareness of indications for device therapy among a broad range of physicians: a survey study"],"prefix":"10.1093","volume":"16","author":[{"given":"Clara","family":"H\u00fcbinette","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars H.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredrik","family":"Gadler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"St\u00e5hlberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,1,22]]},"reference":[{"key":"key\n\t\t\t\t20170522213108_EUT416C1","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522213108_EUT416C2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522213108_EUT416C3","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522213108_EUT416C4","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522213108_EUT416C5","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiac-resynchronization therapy for the prevention of heart-failure events","volume":"361","author":"Moss","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522213108_EUT416C6","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","article-title":"Cardiac-resynchronization therapy for mild-to-moderate heart failure","volume":"363","author":"Tang","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522213108_EUT416C7","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2008.08.027","article-title":"Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms","volume":"52","author":"Linde","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170522213108_EUT416C8","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/europace\/eum189","article-title":"Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association","volume":"9","author":"Vardas","year":"2007","journal-title":"Europace"},{"key":"key\n\t\t\t\t20170522213108_EUT416C9","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/eurjhf\/hfp149","article-title":"Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008","volume":"11","author":"van Veldhuisen","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t20170522213108_EUT416C10","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/europace\/euq282","article-title":"European utilization of the implantable defibrillator: has 10 years changed the \u2018enigma?","volume":"12","author":"Camm","year":"2010","journal-title":"Europace"},{"key":"key\n\t\t\t\t20170522213108_EUT416C11","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ahj.2009.10.011","article-title":"Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF","volume":"158","author":"Curtis","year":"2009","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170522213108_EUT416C12","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.hrthm.2009.08.022","article-title":"Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: findings from IMPROVE HF","volume":"6","author":"Mehra","year":"2009","journal-title":"Heart Rhythm"},{"key":"key\n\t\t\t\t20170522213108_EUT416C13","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/jama.298.13.1525","article-title":"Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure","volume":"298","author":"Hernandez","year":"2007","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170522213108_EUT416C14","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1111\/j.1540-8159.2008.02281.x","article-title":"Low referral rate for prophylactic implantation of cardioverter-defibrillators in a tertiary care medical center","volume":"32","author":"Bradfield","year":"2009","journal-title":"Pacing Clin Electrophysiol"},{"key":"key\n\t\t\t\t20170522213108_EUT416C15","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/europace\/eur354","article-title":"Primary prevention of defibrillator implantation after myocardial infarction: clinical practice and compliance to guidelines","volume":"14","author":"Sjoblom","year":"2012","journal-title":"Europace"},{"key":"key\n\t\t\t\t20170522213108_EUT416C16","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.hrthm.2012.01.029","article-title":"Referring physicians' discordance with the primary prevention implantable cardioverter-defibrillator guidelines: a national survey","volume":"9","author":"Castellanos","year":"2012","journal-title":"Heart Rhythm"},{"key":"key\n\t\t\t\t20170522213108_EUT416C17","first-page":"267","article-title":"Physicians' knowledge and attitudes regarding implantable cardioverter-defibrillators","volume":"17","author":"Sherazi","year":"2010","journal-title":"Cardiol J"},{"key":"key\n\t\t\t\t20170522213108_EUT416C18","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1540-8159.2012.03373.x","article-title":"Questionnaire survey of cardiologists' knowledge, attitudes, and guideline application of implantable cardioverter defibrillator therapy","volume":"35","author":"Sadarmin","year":"2012","journal-title":"Pacing Clin Electrophysiol"},{"key":"key\n\t\t\t\t20170522213108_EUT416C19","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/europace\/eup236","article-title":"A national survey of clinician's knowledge of and attitudes towards implantable cardioverter defibrillators","volume":"11","author":"McHale","year":"2009","journal-title":"Europace"},{"key":"key\n\t\t\t\t20170522213108_EUT416C20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1388-9842(00)00115-X","article-title":"Epidemiology of heart failure in Sweden\u2014a national survey","volume":"3","author":"Mejhert","year":"2001","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t20170522213108_EUT416C21","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/europace\/eut206","article-title":"2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)","volume":"15","author":"Brignole","year":"2013","journal-title":"Europace"},{"key":"key\n\t\t\t\t20170522213108_EUT416C22","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2008.08.027","article-title":"Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms","volume":"52","author":"Linde","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170522213108_EUT416C23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/eurjhf\/hfn006","article-title":"Adequacy of diagnosis and treatment of chronic heart failure in primary health care in Sweden","volume":"11","author":"Dahlstrom","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t20170522213108_EUT416C24","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.ahj.2012.08.002","article-title":"Is heart failure guideline adherence being underestimated? The impact of therapeutic contraindications","volume":"164","author":"Atwater","year":"2012","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170522213108_EUT416C25","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/eurheartj\/ehn196","article-title":"Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians","volume":"29","author":"Remme","year":"2008","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170522213108_EUT416C26","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170522213108_EUT416C27","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0895-4356(97)00126-1","article-title":"Response rates to mail surveys published in medical journals","volume":"50","author":"Asch","year":"1997","journal-title":"J Clin Epidemiol"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/16\/11\/1580\/17428094\/eut416.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T23:08:52Z","timestamp":1565132932000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article-lookup\/doi\/10.1093\/europace\/eut416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,22]]},"references-count":27,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,1,22]]},"published-print":{"date-parts":[[2014,11]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/eut416","relation":{},"ISSN":["1532-2092","1099-5129"],"issn-type":[{"value":"1532-2092","type":"electronic"},{"value":"1099-5129","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1,22]]}}}